FREMONT, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML) announced today that it will webcast its presentation at the Acumen BioFin 9th Annual Healthcare Conference in New York. Gail Page, President & CEO, will provide a company overview at 3:45 p.m. Eastern on Tuesday, November 6, 2007.
A webcast of the presentation will be available live and by replay. To access both the live and archived webcast, please go to http://www.ciphergen.com and click on the "Investors" link. The archived replay will be available for 24 hours after the live presentation and will be accessible for 30 days.
About Vermillion, Inc.
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Vermillion can be found on the Web at http://www.vermillion.com.
|SOURCE Vermillion, Inc.|
Copyright©2007 PR Newswire.
All rights reserved